DK0906243T4 - Oplöselige oxider til biologiske anvendelser - Google Patents

Oplöselige oxider til biologiske anvendelser

Info

Publication number: DK0906243T4
Authority: DK; Denmark
Prior art keywords: biological applications; soluble oxides; xerogel; silica; gel
Prior art date: 1996-05-29

Application number

DK97924045T

Other languages

English (en)

Other versions

DK0906243T3 (da

Inventor

Kauko Kurkela

Antti Yli-Urpo

Ilkka Kangasniemi

Manja Ahola

Heidi Fagerholm

Juha Kiesvaara

Pirjo Kortesuo

Niilo Saarinen

Original Assignee

Delsitech Oy

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-05-29

Filing date

1997-05-29

Publication date

2009-06-08

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26691266&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0906243(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-05-29 Application filed by Delsitech Oy filed Critical Delsitech Oy

2005-10-03 Publication of DK0906243T3 publication Critical patent/DK0906243T3/da

2009-06-08 Application granted granted Critical

2009-06-08 Publication of DK0906243T4 publication Critical patent/DK0906243T4/da

Links

229910002028 silica xerogel Inorganic materials 0.000 abstract 3
239000013543 active substance Substances 0.000 abstract 1
239000002245 particle Substances 0.000 abstract 1
238000003980 solgel method Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0015—Medicaments; Biocides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0031—Hydrogels or hydrocolloids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0042—Materials resorbable by the body
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/02—Surgical adhesives or cements; Adhesives for colostomy devices containing inorganic materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/10—Ceramics or glasses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B33/00—Silicon; Compounds thereof
- C01B33/113—Silicon oxides; Hydrates thereof
- C01B33/12—Silica; Hydrates thereof, e.g. lepidoic silicic acid
- C01B33/16—Preparation of silica xerogels
- C01B33/163—Preparation of silica xerogels by hydrolysis of organosilicon compounds, e.g. ethyl orthosilicate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/30—Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/43—Hormones, e.g. dexamethasone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/64—Animal cells

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Dermatology (AREA)
Engineering & Computer Science (AREA)
Inorganic Chemistry (AREA)
Oral & Maxillofacial Surgery (AREA)
Transplantation (AREA)
Surgery (AREA)
Materials Engineering (AREA)
Pharmacology & Pharmacy (AREA)
Dispersion Chemistry (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Ceramic Engineering (AREA)
Medicinal Preparation (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Silicon Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK97924045T 1996-05-29 1997-05-29 Oplöselige oxider til biologiske anvendelser DK0906243T4 (da)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US1857596P	1996-05-29	1996-05-29
US4242397P	1997-03-27	1997-03-27
PCT/FI1997/000330 WO1997045367A1 (en)	1996-05-29	1997-05-29	Dissolvable oxides for biological applications
EP97924045A EP0906243B2 (en)	1996-05-29	1997-05-29	Dissolvable oxides for biological applications

Publications (2)

Publication Number	Publication Date
DK0906243T3 DK0906243T3 (da)	2005-10-03
DK0906243T4 true DK0906243T4 (da)	2009-06-08

Family

ID=26691266

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK97924045T DK0906243T4 (da)	1996-05-29	1997-05-29	Oplöselige oxider til biologiske anvendelser

Country Status (18)

Country	Link
EP (2)	EP0906243B2 (da)
JP (1)	JP4322315B2 (da)
CN (1)	CN1103320C (da)
AT (1)	ATE301102T1 (da)
AU (1)	AU738176B2 (da)
CA (1)	CA2257172C (da)
CZ (1)	CZ297042B6 (da)
DE (1)	DE69733889T3 (da)
DK (1)	DK0906243T4 (da)
EE (1)	EE03758B1 (da)
ES (1)	ES2244998T5 (da)
HU (1)	HU227939B1 (da)
NO (1)	NO328711B1 (da)
NZ (1)	NZ332968A (da)
PL (1)	PL330191A1 (da)
RU (1)	RU2208582C2 (da)
SK (1)	SK284193B6 (da)
WO (1)	WO1997045367A1 (da)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI980032A0 (fi) *	1998-01-09	1998-01-09	Heikki Matti Eemeli Rauvala	Ny anvaendning av en heparin bindande, med tillvaext foerknippad molekyl
FI109332B (fi)	1998-12-17	2002-07-15	Orion Yhtymae Oyj	Toremifeenin liukoisia koostumuksia
JP4812167B2 (ja)	1999-02-12	2011-11-09	モレキュラーインサイトファーマスーティカルズインコーポレイテッド	薬物輸送用マトリックス、ならびにその作成方法および使用方法
SK10612001A3 (sk) *	1999-02-22	2002-02-05	Bioxid Oy	Spôsob výroby riadene biodegradovateľných keramických vlákien z hydrosólu oxidu kremičitého
FI19991806L (fi) *	1999-08-25	2001-02-26	Yli Urpo Antti	Uusia koostumuksia biologisesti aktiivisen aineen säädettyyn vapauttamiseen, ja niiden valmistus
US6632412B2 (en)	1999-12-01	2003-10-14	Timo Peltola	Bioactive sol-gel derived silica fibers and methods for their preparation
AUPQ573300A0 (en)	2000-02-21	2000-03-16	Australian Nuclear Science & Technology Organisation	Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
JP4979109B2 (ja)	2000-04-21	2012-07-18	ゾル−ゲルテクノロジーズリミテッド	局所的有効成分の増強された配合安定性および送達を示す組成物
US7758888B2 (en)	2000-04-21	2010-07-20	Sol-Gel Technologies Ltd.	Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
JP2004526749A (ja) *	2001-04-04	2004-09-02	デルシテクオサケユキチュア	生分解性キャリアおよびその製造方法
WO2002087648A1 (en) *	2001-04-27	2002-11-07	Vivoxid Oy	Method for improvement of soft tissue attachment and implants making use of said method
AU2003304348A1 (en) *	2002-03-15	2005-02-04	The Trustees Of The University Of Pennsylvania	Fibrous composite for tissue engineering
JP4800922B2 (ja) *	2003-01-24	2011-10-26	ザリサーチファウンデイションオブステイトユニバーシティーオブニューヨーク	光線力学療法用の治療薬を封入するためのセラミックベースナノ粒子及びその使用方法
EA008771B1 (ru)	2003-07-31	2007-08-31	Сол-Джел Текнолоджиз Лтд.	Микрокапсулы, заполненные активными ингредиентами, и способ их приготовления
EP1718564B1 (en) *	2004-02-27	2018-11-14	DelSiTech Oy	Method for preparing adjustably bioresorbable sol-gel derived sio2
EP1602365A1 (en) *	2004-03-03	2005-12-07	Switch Biotech Aktiengesellschaft	Pharmaceutical composition for topical use in form of xerogels or films and methods for production
GB0420016D0 (en)	2004-09-09	2004-10-13	Leuven K U Res & Dev	Controlled release oral delivery system
JP4006002B2 (ja) *	2004-11-26	2007-11-14	キヤノン株式会社	Ｄｎａ担持繊維及びｄｎａ担持繊維シート並びにこれらの製造方法
AU2006274541B2 (en)	2005-08-02	2012-12-13	Sol-Gel Technologies Ltd.	Metal oxide coating of water insoluble ingredients
US20080254082A1 (en)	2005-09-27	2008-10-16	Sol-Gel Technologies Ltd.	Methods for Crop Protection
WO2007129991A1 (en)	2006-05-04	2007-11-15	Agency For Science Technology And Research	Mechanically reversible gel
WO2007141590A1 (en) *	2006-06-06	2007-12-13	Universidad Autonoma Metropolitana	Sol-gel nanostructured titania reservoirs for use in the controlled release of drugs in the central nervous system and method of synthesis
CA2702340C (en)	2006-10-12	2014-12-16	The University Of Queensland	Compositions and methods for modulating immune responses
DE102007061873B4 (de)	2007-01-15	2025-06-26	Bayer Intellectual Property Gmbh	Kieselsol-Material zur Herstellung von biologisch degradierbaren und/oder resorbierbaren Kieselgel-Materialien, dessen Herstellung und Verwendung
KR20090121291A (ko)	2007-02-01	2009-11-25	솔-겔 테크놀로지스 리미티드	산화금속 코팅을 포함한 입자의 제조방법 및 산화금속 코팅을 포함한 입자
FI20070174A0 (fi) *	2007-02-28	2007-02-28	Delsitech Oy	Menetelmä silikakoostumusten valmistamiseksi, silikakoostumukset ja niiden käytöt
JP5344417B2 (ja) *	2007-04-17	2013-11-20	国立大学法人群馬大学	水油界面を利用した薬物−シリカ封入体の製造法
DE102007026043B4 (de) *	2007-06-04	2018-08-16	Jiangsu Synecoun Medical Technology Co., Ltd.	Nicht-toxisches Polyethoxysiloxan-Material zur Herstellung von biologisch resorbierbares und/oder bioaktives Polyethoxysiloxan-Material enthaltenden Artikeln, dessen Herstellung und Verwendung
DE102007061874A1 (de) *	2007-12-19	2009-06-25	Bayer Innovation Gmbh	Nicht-toxisches Polysiloxan-Material zur Herstellung von biologisch resorbierbaren und/oder bioaktiven Polysiloxan-Material enthaltenden Artikeln, dessen Herstellung und Verwendung
DE102008033327A1 (de) *	2008-07-16	2010-01-21	Bayer Innovation Gmbh	Kieselsol-Material mit mindestens einem therapeutisch aktiven Wirkstoff zur Herstellung von biologisch degradierbaren und/oder resorbierbaren Kieselgel-Materialien für die Humanmedizin und/oder Medizintechnik
DE102009053782A1 (de) *	2009-11-19	2011-06-01	BSH Bosch und Siemens Hausgeräte GmbH	Poröses SiO2-Xerogel mit charakteristischer Porengröße, dessen trocknungsstabile Vorstufen und dessen Anwendung
DE102009053784A1 (de) *	2009-11-19	2011-05-26	BSH Bosch und Siemens Hausgeräte GmbH	Verfahren zur Herstellung eines porösen SiO2-Xerogels mit charakteristischer Porengröße durch ein Bottom-Up-Verfahren über eine Vorstufe mit organischen Festkörperskelettstützen
JP5945267B2 (ja) *	2010-04-12	2016-07-05	ユニヴェルシテクロードベルナールリヨン１	有機ケイ素ゾルの急速縮合によって得られるハイブリッド材料の製造方法
EP2417982A1 (en) *	2010-07-30	2012-02-15	Ferring B.V.	Stabilization of gonadotropins
DE102010034695A1 (de) *	2010-08-18	2012-02-23	Gesellschaft zur Förderung von Medizin-, Bio- und Umwelttechnologien e.V.	Xerogele mit homogen eingebetteten Lebensmittelzusätzen und Verfahren zur ihrer Herstellung
EP2635596B8 (en)	2010-11-01	2020-03-11	University of Technology Sydney	Immune-modulating agents and uses therefor
CA2858721C (en)	2011-12-11	2021-03-16	Recro Pharma, Inc.	Intranasal dexmedetomidine compositions and methods of use thereof
CN105050708A (zh)	2012-11-14	2015-11-11	格雷斯公司	含有生物活性材料与无序无机氧化物的组合物
US9687465B2 (en)	2012-11-27	2017-06-27	Sol-Gel Technologies Ltd.	Compositions for the treatment of rosacea
HRP20200134T1 (hr) *	2013-06-24	2020-08-21	Delsitech Oy	Silika hidrogel kompozit
CN104546804A (zh) *	2013-10-09	2015-04-29	上海现代药物制剂工程研究中心有限公司	三维网状立体构型的透皮给药制剂及其制备方法
BR112018006784B1 (pt)	2015-10-22	2023-10-03	Delsitech Oy	Formulação depot compósita de hidrogel e uso da mesma
WO2019012537A1 (en)	2017-07-12	2019-01-17	Sol-Gel Technologies Ltd	COMPOSITIONS COMPRISING ENCAPSULATED TRETTINOIN
GR1010001B (el) *	2019-12-30	2021-05-12	Πυρογενεσις Αβεε	Υδρογελες και ξηρογελες φορεις δραστικων συστατικων αποτελουμενες απο δενδριτικα πολυμερη και πυριτια για εφαρμογες επικαλυψης σε στερεα υποστρωματα

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3846537A (en) *	1972-08-21	1974-11-05	Monsanto Co	Process of preparing silica xerogels
JPH0764543B2 (ja) *	1987-07-24	1995-07-12	富士デヴィソン化学株式会社	球状シリカ及びその製法
IT1216570B (it) *	1988-04-08	1990-03-08	Vectorpharma Int	Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione.
US5200334A (en) *	1991-08-13	1993-04-06	The Regents Of The University Of California	Sol-gel encapsulated enzyme
EP0680753A3 (de) *	1994-05-06	1996-08-28	Feinchemie Gmbh Sebnitz	Metalloxidkomposit mit steuerbarer Wirkstoffabgabe.
DE4422912A1 (de) *	1994-06-30	1996-01-11	Hoechst Ag	Xerogele, Verfahren zu ihrer Herstellung, sowie ihre Verwendung
US5591453A (en) *	1994-07-27	1997-01-07	The Trustees Of The University Of Pennsylvania	Incorporation of biologically active molecules into bioactive glasses

1997
- 1997-05-29 DK DK97924045T patent/DK0906243T4/da active
- 1997-05-29 HU HU9903865A patent/HU227939B1/hu not_active IP Right Cessation
- 1997-05-29 PL PL97330191A patent/PL330191A1/xx unknown
- 1997-05-29 AU AU29641/97A patent/AU738176B2/en not_active Ceased
- 1997-05-29 DE DE69733889T patent/DE69733889T3/de not_active Expired - Lifetime
- 1997-05-29 AT AT97924045T patent/ATE301102T1/de active
- 1997-05-29 EP EP97924045A patent/EP0906243B2/en not_active Expired - Lifetime
- 1997-05-29 RU RU98123591/12A patent/RU2208582C2/ru not_active IP Right Cessation
- 1997-05-29 CA CA002257172A patent/CA2257172C/en not_active Expired - Fee Related
- 1997-05-29 ES ES97924045T patent/ES2244998T5/es not_active Expired - Lifetime
- 1997-05-29 EE EE9800418A patent/EE03758B1/xx unknown
- 1997-05-29 CZ CZ0384598A patent/CZ297042B6/cs not_active IP Right Cessation
- 1997-05-29 SK SK1642-98A patent/SK284193B6/sk not_active IP Right Cessation
- 1997-05-29 WO PCT/FI1997/000330 patent/WO1997045367A1/en not_active Ceased
- 1997-05-29 CN CN97195027A patent/CN1103320C/zh not_active Expired - Lifetime
- 1997-05-29 JP JP54169197A patent/JP4322315B2/ja not_active Expired - Lifetime
- 1997-05-29 EP EP05101502A patent/EP1618896A3/en not_active Withdrawn
- 1997-05-29 NZ NZ332968A patent/NZ332968A/xx not_active IP Right Cessation
1998
- 1998-11-27 NO NO19985534A patent/NO328711B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
DK0906243T3 (da)	2005-10-03
EE9800418A (et)	1999-10-15
EP0906243B2 (en)	2009-04-01
CN1219919A (zh)	1999-06-16
HUP9903865A1 (hu)	2000-04-28
JP2001509122A (ja)	2001-07-10
NO985534D0 (no)	1998-11-27
AU2964197A (en)	1998-01-05
ES2244998T3 (es)	2005-12-16
CZ297042B6 (cs)	2006-08-16
ATE301102T1 (de)	2005-08-15
ES2244998T5 (es)	2009-06-15
EE03758B1 (et)	2002-06-17
CN1103320C (zh)	2003-03-19
SK164298A3 (en)	1999-11-08
EP0906243B1 (en)	2005-08-03
CA2257172A1 (en)	1997-12-04
SK284193B6 (sk)	2004-10-05
HU227939B1 (en)	2012-06-28
EP1618896A2 (en)	2006-01-25
AU738176B2 (en)	2001-09-13
PL330191A1 (en)	1999-04-26
DE69733889T2 (de)	2006-04-13
CZ384598A3 (cs)	1999-07-14
HUP9903865A3 (en)	2000-06-28
NO985534L (no)	1999-01-26
EP0906243A1 (en)	1999-04-07
DE69733889D1 (de)	2005-09-08
NZ332968A (en)	2000-08-25
WO1997045367A1 (en)	1997-12-04
CA2257172C (en)	2005-04-12
DE69733889T3 (de)	2009-10-22
JP4322315B2 (ja)	2009-08-26
RU2208582C2 (ru)	2003-07-20
NO328711B1 (no)	2010-05-03
EP1618896A3 (en)	2010-07-14

Publication	Publication Date	Title
DK0906243T3 (da)	2005-10-03	Oplöselige oxider til biologiske anvendelser
WO1997014806A3 (en)	1997-08-21	Delivery of biologically active polypeptides
DE19580865D2 (de)	1998-03-19	Implantat, Implantationsverfahren und Applikationsvorrichtung
PT946143E (pt)	2006-08-31	Composicao gelificada a base de nitro-imidazole.
NO995313L (no)	1999-12-29	Mikroartikler nyttige som ultrasoniske kontrastmidler og til levering av legemidler i blodbanen
AU2002231058A1 (en)	2002-07-01	Biologically active agent delivery apparatus and method
BR9609176A (pt)	1999-08-24	Composi-{es de agente biolÄgico
FI965203A0 (fi)	1996-12-23	Morfiinia, polypyrrolidonia ja polyalkyleenioksidia sisältävä koostumus
IE892771L (en)	1990-02-28	The use of asymmetric membranes in delivery devices
BR9501319A (pt)	1996-03-05	Composição tópica cosmetica e/ou dermatológica utilização desta composição e processo de tratamento cosmético
AU9278898A (en)	1999-04-23	Process for preparing biologically compatible polymers and their use in medical devices
AU1756799A (en)	1999-06-16	Epoxidation catalyst, its use and epoxidation method in the presence of said catalyst
IL136226A0 (en)	2001-05-20	Flow regulating implant, method of manufacturing, and delivery device
EP1169071A4 (en)	2007-07-18	INJURY THERAPY DEVICE
DE69102405D1 (de)	1994-07-14	Aktivkohlesubstanz, Herstellungsverfahren und Anwendung.
AU2638795A (en)	1996-01-15	In situ gel-forming delivery vehicle for bio-affecting substances, and method of use
IS1930B (is)	2004-05-18	Notkun samsetningar H+, K+ -ATPasa tálma og sykurstera í meðhöndlun á nefsepagerum
AU2658195A (en)	1995-12-21	Immobilization of biologically active materials and diagnostic agents in cross-linked poly(organophosphazenes)
IT1293088B1 (it)	1999-02-11	Microparticelle per il rilascio controllato di molecole biologicamente attive e loro uso in terapia, profilassi e diagnostica in vitro e in
AU1435899A (en)	1999-06-16	Epoxidation catalyst, its use and epoxidation method in the presence of said catalyst
RU95105648A (ru)	1998-02-10	Средство для лечения ран
ITRM940040A0 (it)	1994-01-28	Dispositivo e procedimento per realizzare protesi dentarie mobili.
FR2743713B1 (fr)	1998-07-17	Unite chirurgicale, dentaire notamment, autonome et mobile
EP0885848A4 (en)	2000-12-20	METHOD FOR THE ELECTROCHEMICAL TREATMENT OF AQUEOUS SOLUTIONS AND DEVICE FOR CARRYING OUT SAID METHOD
UA23303A (uk)	1998-08-31	Препарат "флавосорб", який має аhтирадикальhу і детоксикуючу дію, та спосіб його одержаhhя